Molecular approach to uterine leiomyosarcoma: LMP2-deficient mice as an animal model of spontaneous uterine leiomyosarcoma

Sarcoma

Volumn 2011, Issue , 2011, Pages

  Hayashi, Takuma ^a,b   Horiuchi, Akiko ^c   Sano, Kenji ^d   Hiraoka, Nobuyoshi ^e   Kanai, Yae ^e   Shiozawa, Tanri ^c   Tonegawa, Susumu ^f   Konishi, Ikuo ^g  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SHINSHU UNIVERSITY HOSPITAL   (Japan)

^e NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^g KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTERFERON REGULATORY FACTOR 1; LOW MOLECULAR MASS POLYPEPTIDE 2; POLYPEPTIDE; UNCLASSIFIED DRUG;

BENIGN TUMOR; CANCER RISK; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR DIAGNOSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; TUMOR SUPPRESSOR GENE; UTERUS LEIOMYOSARCOMA; UTERUS SARCOMA;

EID: 79955118357     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2011/476498     Document Type: Review

References (38)

1. Zaloudek C., Hendrickson M. R., Kurman R. J., Mesenchymal tumors of the uterus Blaustein's Pathology of the Female Genital Tract 2002 5th New York, NY, USA Springer 561 578
2. Lin J. F., Slomovitz B. M., Uterine sarcoma 2008 Current Oncology Reports 2008 10 6 512 518
3. Amant F., Coosemans AN., Debiec-Rychter M., Timmerman D., Vergote I., Clinical management of uterine sarcomas The Lancet Oncology 2009 10 12 1188 1198
4. Miettinen M., Fetsch J. F., Evaluation of biological potential of smooth muscle tumours Histopathology 2006 48 1 97 105
5. Brooks S. E., Zhan M., Cote T., Baquet C. R., Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 19891999 Gynecologic Oncology 2004 93 1 204 208 (Pubitemid 38429571)
6. Dusenbery K. E., Potish R. A., Judson P., Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus Gynecologic Oncology 2004 94 1 191 196 (Pubitemid 38950519)
7. Wu T. I., Chang T. C., Hsueh S., Hsu K. H., Chou H. H., Huang H. J., Lai C. H., Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma Gynecologic Oncology 2006 100 1 166 172 (Pubitemid 41815068)
8. Maniatis T., A ubiquitin ligase complex essential for the NF- B, Wnt/Wingless, and Hedgehog signaling pathways Genes and Development 1999 13 5 505 510 (Pubitemid 29131874)
9. Groettrup M., Khan S., Schwarz K., Schmidtke G., Interferon- inducible exchanges of 20S proteasome active site subunits: why? Biochimie 2001 83 3-4 367 372 (Pubitemid 32293659)
10. Nakajima C., Uekusa Y., Iwasaki M., Yamaguchi N., Mukai T., Gao P., Tomura M., Ono S., Tsujimura T., Fujiwara H., Hamaoka T., A role of interferon- (IFN- ) in tumor immunity: T cells with the capacity to reject tumor cells are generated but fail to migrate to tumor sites in IFN- -deficient mice Cancer Research 2001 61 8 3399 3405 (Pubitemid 32695032)
11. Shankaran V., Ikeda H., Bruce A. T., White J. M., Swanson P. E., Old L. J., Schreiber R. D., IFN, and lymphocytes prevent primary tumour development and shape tumour immunogenicity Nature 2001 410 6832 1107 1111 (Pubitemid 32391043)
12. Gaczynska M., Rock K. L., Goldberg A. L., -interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes Nature 1993 365 6443 264 267 (Pubitemid 23282087)
13. Delp K., Momburg F., Hilmes C., Huber C., Seliger B., Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin Bone Marrow Transplantation 2000 25 supplement 2 S88 S95
14. Dunn G. P., Bruce A. T., Ikeda H., Old L. J., Schreiber R. D., Cancer immunoediting: from immunosurveillance to tumor escape Nature Immunology 2002 3 11 991 998 (Pubitemid 35363648)
15. Dunn G. P., Old L. J., Schreiber R. D., The immunobiology of cancer immunosurveillance and immunoediting Immunity 2004 21 2 137 148 (Pubitemid 39094044)
16. Van Kaer L., Ashton-Rickardt P. G., Eichelberger M., Gaczynska M., Nagashima K., Rock K. L., Goldberg A. L., Doherty P. C., Tonegawa S., Altered peptidase and viral-specific T cell response in LMP2 mutant mice Immunity 1994 1 7 533 541
17. Hayashi T., Faustman D. L., Development of spontaneous uterine tumors in low molecular mass polypeptide-2 knockout mice Cancer Research 2002 62 1 24 27 (Pubitemid 34073979)
18. Hollstein M., Sidransky D., Vogelstein B., Harris C. C., p53 mutations in human cancers Science 1991 253 5015 49 53 (Pubitemid 21917115)
19. Brucet M., Marqus L., Sebastin C., Lloberas J., Celada A., Regulation of murine Tap1 and Lmp2 genes in macrophages by interferon gamma is mediated by STAT1 and IRF-1 Genes and Immunity 2004 5 1 26 35 (Pubitemid 38967626)
20. Hayashi T., Kobayashi Y., Kohsaka S., Sano K., The mutation in the ATP-binding region of JAK1, identified in human uterine leiomyosarcomas, results in defective interferon- inducibility of TAP1 and LMP2 Oncogene 2006 25 29 4016 4026 (Pubitemid 44024864)
21. Yanagi S., Shimbara N., Tamura T. A., Tissue and cell distribution of a mammalian proteasomal ATPase, MSS1, and its complex formation with the basal transcription factors Biochemical and Biophysical Research Communications 2000 279 2 568 573 (Pubitemid 32016756)
22. Lassot I., Latreille D., Rousset E., Sourisseau M., Linares L. K., Chable-Bessia C., Coux O., Benkirane M., Kiernan R. E., The proteasome regulates HIV-1 transcription by both proteolytic and nonproteolytic mechanisms Molecular Cell 2007 25 3 369 383 (Pubitemid 46199286)
23. Harada H., Kitagawa M., Tanaka N., Yamamoto H., Harada K., Ishihara M., Taniguchi T., Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2 Science 1993 259 5097 971 974 (Pubitemid 23080666)
24. Tanaka N., Ishihara M., Lamphier M. S., Nozawa H., Matsuyama T., Mak T. W., Aizawa S., Tokino T., Oren M., Taniguchi T., Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage Nature 1996 382 6594 816 818 (Pubitemid 26299566)
25. Sherr C. J., The pezcoller lecture: cancer cell cycles revisited Cancer Research 2000 60 14 3689 3695 (Pubitemid 32204552)
26. Koepp D. M., Schaefer L. K., Ye X., Keyomarsi K., Chu C., Harper J. W., Elledge S. J., Phosphorylation-dependent ubiquitination of cyctin E by the SCF ubiquitin ligase Science 2001 294 5540 173 177 (Pubitemid 32952972)
27. Matsumoto Y., Maller J. L., A centrosomal localization signal in cyclin E required for Cdk2-independent S phase entry Science 2004 306 5697 885 888 (Pubitemid 39447000)
28. Liang S. X., Lakshmanan Y., Woda B. A., Jiang Z., A high-grade primary leiomyosarcoma of the bladder in a survivor of retinoblastoma Archives of Pathology and Laboratory Medicine 2001 125 9 1231 1234 (Pubitemid 32845805)
29. Venkatraman L., Goepel J. R., Steele K., Dobbs S. P., Lyness R. W., McCluggage W. G., Soft tissue, pelvic, and urinary bladder leiomyosarcoma as second neoplasm following hereditary retinoblastoma Journal of Clinical Pathology 2003 56 3 233 236 (Pubitemid 36308042)
30. Calo E., Quintero-Estades J. A., Danielian P. S., Nedelcu S., Berman S. D., Lees J. A., Rb regulates fate choice and lineage commitment in vivo Nature 2010 466 7310 1110 1114
31. Zhai Y. L., Kobayashi Y., Mori A., Or A. II, Nikaido T., Konishi I., Fuj S. II, Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas International Journal of Gynecological Pathology 1999 18 1 20 28 (Pubitemid 29028841)
32. Akhan S. E., Yavuz E., Tecer A., Iyibozkurt C. A., Topuz S., Tuzlali S., Bengisu E., Berkman S., The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study Gynecologic Oncology 2005 99 1 36 42 (Pubitemid 41354580)
33. Wang H. X., Wang H. M., Li Q. L., Lin H. Y., Qian D., Zhu C., Expression of proteasome subunits low molecular mass polypeptide (LMP) 2 and LMP7 in the endometrium and placenta of rhesus monkey (Macaca mulatta) during early pregnancy Biology of Reproduction 2004 71 4 1317 1324 (Pubitemid 39249818)
34. Kanamori T., Takakura K., Mandai M., Kariya M., Fukuhara K., Kusakari T., Momma C., Shime H., Yagi H., Konishi M., Suzuki A., Matsumura N., Nanbu K., Fujita J., Fuj S. II, PEP-19 overexpression in human uterine leiomyoma Molecular Human Reproduction 2003 9 11 709 717 (Pubitemid 37483958)
35. Wang L., Felix J. C., Lee J. L., Tan P. Y., Tourgeman D. E., O'Meara A. T., Amezcua C. A., The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus Gynecologic Oncology 2003 90 2 402 406 (Pubitemid 36952035)
36. Ylisaukko-Oja S. K., Kiuru M., Lehtonen H. J., Lehtonen R., Pukkala E., Arola J., Launonen V., Aaltonen L. A., Analysis of fumarate hydratase mutations in a population-based series of early onset uterine leiomyosarcoma patients International Journal of Cancer 2006 119 2 283 287
37. Horiuchi A., Nikaido T., Ito K., Zhai Y. L., Or A. II, Taniguchi S., Toki T., Fuj S. II, Reduced expression of calponin h1 in leiomyosarcoma of the uterus Laboratory Investigation 1998 78 7 839 846 (Pubitemid 28347880)
38. Horiuchi A., Nikaido T., Taniguchi S., Fujii S., Possible role of calponin h1 as a tumor suppressor in human uterine leiomyosarcoma Journal of the National Cancer Institute 1999 91 9 790 796 (Pubitemid 29239059)